Cargando…
Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss
The prevalence of obesity has increased worldwide, and approximately 25%–35% of the adult population is obese in some countries. The excess of body fat is associated with adverse health consequences. Considering the limited efficacy of diet and exercise in the current obese population and the use of...
Autores principales: | Barja-Fernandez, S, Leis, R, Casanueva, FF, Seoane, LM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257050/ https://www.ncbi.nlm.nih.gov/pubmed/25489237 http://dx.doi.org/10.2147/DDDT.S53129 |
Ejemplares similares
-
Peripheral Signals Mediate the Beneficial Effects of Gastric Surgery in Obesity
por: Barja-Fernández, Silvia, et al.
Publicado: (2015) -
How to Ensure Fiscal Sustainability in Russia
por: Sokolov, I. A., et al.
Publicado: (2021) -
Circulating Pro-Uroguanylin Levels In Children And Their Relation To Obesity, Sex And Puberty
por: Folgueira, Cintia, et al.
Publicado: (2018) -
Ensuring Quality, Safety and Efficacy
por: Dukes, Graham
Publicado: (2006) -
FNDC5 is produced in the stomach and associated to body composition
por: Barja-Fernández, S., et al.
Publicado: (2016)